Nisa Investment Advisors’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735 | Sell |
361
-241
| -40% | -$491 | ﹤0.01% | 2799 |
|
|
2025
Q1 | $981 | Buy |
602
+338
| +128% | +$551 | ﹤0.01% | 2642 |
|
|
2024
Q4 | $483 | Buy |
264
+231
| +700% | +$423 | ﹤0.01% | 2837 |
|
|
2024
Q3 | $191 | Buy |
+33
| New | +$191 | ﹤0.01% | 2858 |
|
|
2023
Q2 | – | Sell |
-144
| Closed | -$1K | – | 2834 |
|
|
2023
Q1 | $1K | Buy |
144
+7
| +5% | +$49 | ﹤0.01% | 2403 |
|
|
2022
Q4 | $3K | Hold |
137
| – | – | ﹤0.01% | 2339 |
|
|
2022
Q3 | $4K | Hold |
137
| – | – | ﹤0.01% | 2320 |
|
|
2022
Q2 | $3K | Hold |
137
| – | – | ﹤0.01% | 2320 |
|
|
2022
Q1 | $6K | Sell |
137
-490
| -78% | -$21.5K | ﹤0.01% | 2286 |
|
|
2021
Q4 | $31K | Sell |
627
-593
| -49% | -$29.3K | ﹤0.01% | 1844 |
|
|
2021
Q3 | $105 | Hold |
1,220
| – | – | ﹤0.01% | 1676 |
|
|
2021
Q2 | $136 | Buy |
1,220
+1,042
| +585% | +$116 | ﹤0.01% | 1557 |
|
|
2021
Q1 | $20 | Sell |
178
-419
| -70% | -$47 | ﹤0.01% | 2134 |
|
|
2020
Q4 | $63K | Sell |
597
-255
| -30% | -$26.9K | ﹤0.01% | 1920 |
|
|
2020
Q3 | $119K | Sell |
852
-362
| -30% | -$50.6K | ﹤0.01% | 1491 |
|
|
2020
Q2 | $393K | Buy |
1,214
+1,120
| +1,191% | +$363K | ﹤0.01% | 1105 |
|
|
2020
Q1 | $8K | Buy |
+94
| New | +$8K | ﹤0.01% | 1888 |
|
|
2017
Q4 | – | Sell |
-1,217
| Closed | -$93K | – | 1845 |
|
|
2017
Q3 | $93K | Buy |
+1,217
| New | +$93K | ﹤0.01% | 1384 |
|